Abstract

While multiple rodent preclinical studies, and to a lesser extent human clinical trials, claim the feasibility, safety, and potential clinical benefit of cell grafting in the central nervous system (CNS), currently only little convincing knowledge exists regarding the actual fate of the grafted cells and their effect on the surrounding environment (or vice versa). Our preceding studies already indicated that only a minor fraction of the initially grafted cell population survives the grafting process, while the surviving cell population becomes invaded by highly activated microglia/macrophages and surrounded by reactive astrogliosis. In the current study, we further elaborate on early cellular and inflammatory events following syngeneic grafting of eGFP(+) mouse embryonic fibroblasts (mEFs) in the CNS of immunocompetent mice. Based on obtained quantitative histological data, we here propose a detailed mathematically derived working model that sequentially comprises hypoxia-induced apoptosis of grafted mEFs, neutrophil invasion, neoangiogenesis, microglia/macrophage recruitment, astrogliosis, and eventually survival of a limited number of grafted mEFs. Simultaneously, we observed that the cellular events following mEF grafting activates the subventricular zone neural stem and progenitor cell compartment. This proposed model therefore further contributes to our understanding of cell graft-induced cellular responses and will eventually allow for successful manipulation of this intervention.

Highlights

  • While current clinical treatment options for many neurodegenerative diseases and injuries of the central nervous system (CNS) are mainly based on anti-inflammatory and/or symptomatic therapy, actual regeneration of dysfunctional or lost tissue might be facilitated by means of cell and/or tissue transplantation

  • Given the inherent invasiveness of a cell-grafting procedure in the CNS and the contrasting ease by which such an intervention creates experimental and clinical hope to cure complex CNS diseases or traumata, a thorough characterization of the cellular events following cell grafting in the CNS is inevitable to claim safety and efficacy of cell-based regenerative therapies

  • We have further contributed to the characterization of cellular events following mouse embryonic fibroblasts (mEFs) grafting into the CNS

Read more

Summary

Introduction

While current clinical treatment options for many neurodegenerative diseases and injuries of the central nervous system (CNS) are mainly based on anti-inflammatory and/or symptomatic therapy, actual regeneration of dysfunctional or lost tissue might be facilitated by means of cell and/or tissue transplantation. Direct cell grafting into degenerating or injured CNS tissue might overcome the need for (directed) migration of the cell graft toward the CNS [15,30] Following this approach, it is of utmost importance to clearly define the desired clinical effect: either one aims to graft a (genetically modified) cell population to provide trophic support for degenerating or injured CNS tissue, or one aims at functional integration of the grafted (neural) cell population. Despite numerous reports claiming successful grafting of fibroblasts, mesenchymal stem cells (MSCs) and neural

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call